Exagen Inc
NASDAQ:XGN
Exagen Inc
Total Other Income
Exagen Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Exagen Inc
NASDAQ:XGN
|
Total Other Income
$1.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Exagen Inc's Total Other Income?
Total Other Income
1.5m
USD
Based on the financial report for Dec 31, 2023, Exagen Inc's Total Other Income amounts to 1.5m USD.
What is Exagen Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
69%
Over the last year, the Total Other Income growth was 83%. The average annual Total Other Income growth rates for Exagen Inc have been 16% over the past three years , 69% over the past five years .